Anyone who sells at this level is nuts. The OralTab is about to hit the street and as you can see from the logs, we are at the end of the EMET share sell. I think people realize, with such a low float company, the introduction is going to have a profound impact on the share price and there is a very short supply of stock available. Maybe Symtomax will become that publicly traded company they have been stating they want to be with a simple deal with GCAN. They do refer to the OralTab as 'OURS' in their bond presentation to the hedge funds, institutional investors and high end investors. There is a reason why Symtomax hooked up with GCAN and I don't think it stops at the OralTab.

I stand by my thoughts on this and that is why many of us are holding for levels much higher. There is something bigger, IMHO, going on behind the scene than just a relationship. This stock is not a flipping stock because of the level it is now. There is no shorting it is simply if you believe you are in and if you don't you are out. So much third party confirmation, a T/A wide open to communicate to track share structure and the actual presentation putting GCAN as one of the key selling features for the bond offering.

I have also stated the logs show strong accumulation of GCAN shares since the Tax loss selling ended at the end of the year 2019. Someone knows something the street does not. There has been some very large buys lately.

There is about 12 very successful business people running the 2 companies involved with the introduction of OralTab with impeccable reputations of being successul business people. Anyone who may believe that these 12 people have suddenly become 'scamster' is obsurd to say the least. I am betting on them to continue to do what they do best and that is to bring new companies and new products to the market.

JMHO